NNMRANeumora Therapeutics, Inc.

Neumora Therapeutics, Inc.

NMRA

$0.44-8.07%

End of day · as of Oct 12, 2026, 8:00 PM ET

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive NMRA chart

  • Mkt cap

    $283.48M

  • EV/Sales

    N/A

  • P/E ratio

    N/A

  • Revenue

    N/A

  • EPS (H1 2026)

    $-1.00

  • Gross Margin

    N/A

  • Profit Margin

    N/A

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

Live NMRA terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

NMRA — Neumora Therapeutics, Inc. · $283.5M cap

NMRA Key Statistics

  • Market Cap: $283.5M
  • P/B Ratio: 4.02
  • Previous Close: $0.48
  • Volume: 1,209,406
  • Day Range: $0.44 – $0.48

NMRA FAQ

What industry is NMRA in?

Neumora Therapeutics, Inc. (NMRA) is a biotechnology company in the Healthcare sector.

What is NMRA's market cap?

Neumora Therapeutics, Inc. (NMRA) market capitalization is $283.5M on the latest cached snapshot.

What are NMRA's previous close, day range, and volume?

Neumora Therapeutics, Inc. (NMRA) cached previous close $0.48; day range $0.44 – $0.48; volume 1,209,406. Session quote: https://lician.com/quote/nmra

Live NMRA terminal loads when you scroll near this section.